as well as BMS’ pulrodemstat - an LSD1 inhibitor inherited with its Celgene acquisition. Some clinical candidates have fallen by the wayside however, including GSK’s GSK2879552, which was ...

Image Caption: The structure of LSD1. By expanding our understanding of LSD1 and its modifications, this research provides a foundation for developing novel therapeutic strategies, offering hope ...

A new review highlights the pivotal role of LSD1 (lysine-specific demethylase 1) in regulating critical cellular processes and its implications for human diseases. This article sheds light on how ...